within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G04B_Urologicals.G04BE09_Vardenafil;

model Vardenafil
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.15,
    Cl = 1.5555555555555555e-05,
    adminDuration = 600,
    adminMass = 20 / 1000000,
    adminCount = 1,
    Vd = 0.117,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.024166666666666666,
    Tlag = 10.200000000000001,
    Vdp = 0.122,
    k12 = 3.388888888888889e-05,
    k21 = 3.388888888888889e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Vardenafil</td></tr><tr><td>ATC code:</td><td>G04BE09</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>20</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>117</td><td>L</td></tr>
    <tr><td>clearance:</td><td>56</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor, used to treat erectile dysfunction in men. It works by increasing blood flow to the penis during sexual stimulation. Vardenafil is approved and currently available as a prescription medicine in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult males following a single oral dose.</p><h4>References</h4><ol><li><p>Eardley, I (2004). Vardenafil: a new oral treatment for erectile dysfunction. <i>International journal of clinical practice</i> 58(8) 801–806. DOI:<a href=\"https://doi.org/10.1111/j.1368-5031.2004.00213.x\">10.1111/j.1368-5031.2004.00213.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15372854/\">https://pubmed.ncbi.nlm.nih.gov/15372854</a></p></li><li><p>Briganti, A, et al., &amp; Montorsi, F (2005). Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. <i>Nature clinical practice. Urology</i> 2(5) 239–247. DOI:<a href=\"https://doi.org/10.1038/ncpuro0186\">10.1038/ncpuro0186</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16474835/\">https://pubmed.ncbi.nlm.nih.gov/16474835</a></p></li><li><p>Crowe, SM, &amp; Streetman, DS (2004). Vardenafil treatment for erectile dysfunction. <i>The Annals of pharmacotherapy</i> 38(1) 77–85. DOI:<a href=\"https://doi.org/10.1345/aph.1D019\">10.1345/aph.1D019</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/14742800/\">https://pubmed.ncbi.nlm.nih.gov/14742800</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.G.G04BE09 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Vardenafil;
